Business
NeuroOne Medical Technologies Corporation Announces Pricing of $8.0 Million Public Offering of Common Stock
EDEN PRAIRIE, Minn., April 04, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced today the pricing of an underwritten registered public offering of 16,000,000 shares of its common stock at a price of $0.50 per share. Ladenburg Thalmann & Co. Inc. is acting as sole book-running manager for the offering.
About this update from Neuroone Medical Technologies Corporation
[{"type":"image","alt":"NeuroOne Medical Technologies Corporation","displaySize":"","headline":null,"caption":"NeuroOne Medical Technologies Corporation","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":48,"url":"https://media.zenfs.com/en/globenewswire.com/819fe13d4f4c15d1a815f2aae4dd578b"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/pp0tg2T4IB9hXCYxVLu0sA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTY3O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/819fe13d4f4c15d1a815f2aae4dd578b","width":300,"height":48}},"lazy":false},{"type":"text","content":"EDEN PRAIRIE, Minn., April 04, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced today the pricing of an underwritten registered public offering of 16,000,000 shares of its common stock at a price of $0.50 per share.","length":412,"tagName":"p"},{"type":"text","content":"Ladenburg Thalmann & Co. Inc. is acting as sole book-running manager for the offering.","length":90,"tagName":"p"},{"type":"text","content":"All of the shares of common stock to be sold in the offering will be sold by the Company. In addition, the Company has granted the underwriter a 45-day option to purchase up to an additional 2,400,000 shares of its common stock at the public offering price less the underwriting discount.","length":288,"tagName":"p"},{"type":"text","content":"The gross proceeds to the Company from this offering, before deducting underwriting discounts and commissions and offering expenses, but excluding any exercise of the underwriter’s option to purchase additional shares, are expected to be $8,000,000. The Company intends to use the net proceeds from this offering for general working capital purposes. The offering is expected to close on or about April 7, 2025, subject to customary closing conditions.","length":452,"tagName":"p"},{"type":"text","content":"The shares will be issued pursuant to a shelf registration statement on Form S-3 (File No. 333-279871) that was declared effective by the U.S. Securities and Exchange Commission (“SEC”), on August 16, 2024. A preliminary prospectus supplement and accompanying prospectus relating to the offering was filed with the SEC and is availab...